Vivo Bio Tech Q2 FY27 Results: Net Profit ₹1.1 Cr, Up 22.2% YoY
Vivo Bio Tech Ltd reported revenue from operations of ₹17.2 Cr (+31.3% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.1 Cr · +22.2% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Vivo Bio Tech Ltd reported revenue from operations of ₹17.2 Cr (+31.3% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for Q2 FY27.
Vivo Bio Tech Ltd reported revenue from operations of ₹14.3 Cr (+14.4% YoY) and net profit of ₹0.2 Cr (-84.6% YoY) for Q1 FY27.
Vivo Bio Tech Ltd reported revenue from operations of ₹14.2 Cr (+15.4% YoY) and a net loss of ₹5.2 Cr for Q4 FY26.
Vivo Bio Tech approved its FY26 audited financial results and the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director. The company also appointed a consultant for an upcoming merger scheme.